source
- Why Oura is buying CounselEvery year at HLTH, there is usually one piece of news that everyone has an opinion about. This year, it was Oura buying Counsel Health. That’s for good reason. It’s been rare to see a ...Endpoints · 49m ago↗ source
- STAT+: Epic defends competitive practices; promises AI access to recordsIn this edition of STAT Health Tech: EHR giant, Epic defends its competitive tactics, new data on AI and health care costs, and HLTH news.STAT · 2h ago↗ source
- Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic diseaseSanofi’s Infilbray is designed to cross the blood-brain barrier, allowing the drug to prevent the toxic buildup of disease-causing lipids in the brain for patients with type 3 Gaucher disease.BioSpace · 2h ago